Derangement of cardiac energetics contributes to the progression to heart failure

被引：0
|
作者：
Sano, Motoaki
Fukuda, Keiichi
Izumi, Yasukatsu
Schneider, Michael D.
机构：
[1] Keio Univ, Sch Med, Dept Regenerat Med & Advanced Cardiac Therapeut, Tokyo, Japan
[2] Baylor Coll Med, Ctr Cardiovasc Dev, Houston, TX 77030 USA
来源：
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY | 2006年 / 41卷 / 06期
关键词：
heart failure; metabolism; PGC-1;
D O I：
10.1016/j.yjmcc.2006.08.023
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1040 / 1040
页数：1
相关论文
共 50 条
  • [41] Neurohumoral, cardiac and inflammatory markers in the evaluation of heart failure severity and progression
    Polyakova, Ekaterina A.
    Mikhaylov, Evgeny N.
    Sonin, Dmitry L.
    Cheburkin, Yuri, V
    Galagudza, Mikhail M.
    JOURNAL OF GERIATRIC CARDIOLOGY, 2021, 18 (01) : 47 - 66
  • [42] Neurohumoral, cardiac and inflammatory markers in the evaluation of heart failure severity and progression
    Ekaterina A Polyakova
    Evgeny N Mikhaylov
    Dmitry L Sonin
    Yuri V Cheburkin
    Mikhail M Galagudza
    Journal of Geriatric Cardiology, 2021, 18 (01) : 47 - 66
  • [43] ASSOCIATION OF PLASMA METABOLITES AND CARDIAC MITOCHONDRIAL FUNCTION WITH HEART FAILURE PROGRESSION
    Lanfear, David E.
    She, Ruicong
    Gardell, Stephen
    Luzum, Jasmine
    Williams, L. Keoki
    Sabbah, Hani N.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2023, 81 (08) : 435 - 435
  • [44] Impairment of ultrastructure and cytoskeleton during progression of cardiac hypertrophy to heart failure
    Gupta, Anasuya
    Gupta, Sudhiranjan
    Young, David
    Das, Biswajit
    McMahon, James
    Sen, Subha
    LABORATORY INVESTIGATION, 2010, 90 (04) : 520 - 530
  • [45] Impact of KChIP2 on cardiac electrophysiology and the progression of heart failure
    Grubb, Soren
    Calloe, Kirstine
    Thomsen, Morten B.
    FRONTIERS IN PHYSIOLOGY, 2012, 3
  • [46] Effects of cardiac resynchronization therapy on disease progression in chronic heart failure
    Donal, E
    Leclercq, C
    Linde, C
    Daubert, JC
    EUROPEAN HEART JOURNAL, 2006, 27 (09) : 1018 - 1025
  • [47] Association of plasma metabolites and cardiac mitochondrial function with heart failure progression
    Venkateswaran, Vandana Revathi
    She, Ruicong
    Gardell, Stephen J.
    Luzum, Jasmine A.
    Gupta, Ramesh
    Zhang, Kefei
    Williams, L. Keoki
    Sabbah, Hani N.
    Lanfear, David E.
    ESC HEART FAILURE, 2025,
  • [48] FABP3 Deficiency Exacerbates Metabolic Derangement in Cardiac Hypertrophy and Heart Failure via PPARα Pathway
    Zhuang, Lingfang
    Mao, Ye
    Liu, Zizhu
    Li, Chenni
    Jin, Qi
    Lu, Lin
    Tao, Rong
    Yan, Xiaoxiang
    Chen, Kang
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2021, 8
  • [49] Decreased phosphodiesterase activity in the cardiac ryanodine receptor Ca2+release channel contributes to heart failure progression following myocardial infarction
    Lehnart, SE
    Wehrens, XH
    Reiken, S
    Warrier, S
    Belevych, AE
    Harvey, RD
    Richter, W
    Jin, SLC
    Conti, M
    Marks, AR
    CIRCULATION RESEARCH, 2005, 97 (11) : 1204 - 1204
  • [50] Extracellular vesicular MicroRNA-27a*contributes to cardiac hypertrophy in chronic heart failure
    Tian, Changhai
    Hu, Guoku
    Gao, Lie
    Hackfort, Bryan T.
    Zucker, Irving H.
    JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2020, 143 : 120 - 131
12345